What did Delic Holdings Inc. pay for Ketamine Infusion Centers?

Delic Holdings Inc. acquired Ketamine Infusion Centers for $2.3M in 2021, equivalent to 1.50x revenue. Target revenue was approximately $1.5M.

What does Ketamine Infusion Centers do?

Ketamine Infusion Centers is a pharmacy business.

What multiple did Delic Holdings Inc. pay for Ketamine Infusion Centers?

1.50x revenue, based on disclosed deal value of $2.3M and disclosed financials.

M&A TRANSACTION · 2021

Ketamine Infusion Centers acquired by Delic Holdings Inc.

$2.3M· 1.50x revenue

Target

Ketamine Infusion Centers

Acquirer

Delic Holdings Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$1.5M

EBITDA

—

Deal Value

$2.3M

EV/EBITDA

—

Context

This $2.3M acquisition of Ketamine Infusion Centers by Delic Holdings Inc. sits in the pharmacy sub-vertical. Delic Holdings Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own pharmacy

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Ketamine Infusion Centers acquisition.

Citation: ExitValue.ai. (2021). Ketamine Infusion Centers acquired by Delic Holdings Inc.. https://exitvalue.ai/deals/ketamine-infusion-centers-acquired-by-delic-holdings-inc-hc-2021-0108